| Madhavi Ryali, MD | |
|
133 E Brush Hill Rd Unit 301, Nephrology Associates Of Northern Illinois, Elmhurst, IL 60126-5661 | |
| (630) 832-2183 | |
| (630) 832-2184 |
| Full Name | Madhavi Ryali |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 21 Years |
| Location | 133 E Brush Hill Rd Unit 301, Elmhurst, Illinois |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356453823 | NPI | - | NPPES |
| 036116063 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 036116063 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc - Elmhurst Dialysis Center | Elmhurst, IL | Dialysis facility |
| Fmc - Dupage Peritoneal Dialysis Services | Elmhurst, IL | Dialysis facility |
| Elmhurst Memorial Hospital | Elmhurst, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nani-ihp Llc | 3375767486 | 6 |
| Elmhurst Memorial Healthcare | 9638168602 | 182 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Abacavir Sulfate Tablets, 60 mg. The NDA is based on the reference listed drug Ziagen® by ViiV Healthcare.
Support for eliminating existing exemptions, except for medical reasons, from immunization laws was among the policy recommendations adopted last weekend at the summer meeting of the Board of Regents of the American College of Physicians.
The New York Times reports that the nation's life-expectancy trend has reversed by four years since 1990 for the country's least-educated whites.
An improved physical condition with these exercises helps improve mobility in certain daily activities, increasing the quality of life of people with chronic kidney disease.
› Verified 6 days ago
| Entity Name | Nephrology Associates Of Northern Illinois Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124069182 PECOS PAC ID: 2163328675 Enrollment ID: O20031208000313 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Abacavir Sulfate Tablets, 60 mg. The NDA is based on the reference listed drug Ziagen® by ViiV Healthcare.
Support for eliminating existing exemptions, except for medical reasons, from immunization laws was among the policy recommendations adopted last weekend at the summer meeting of the Board of Regents of the American College of Physicians.
The New York Times reports that the nation's life-expectancy trend has reversed by four years since 1990 for the country's least-educated whites.
An improved physical condition with these exercises helps improve mobility in certain daily activities, increasing the quality of life of people with chronic kidney disease.
› Verified 6 days ago
| Entity Name | Elmhurst Memorial Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457493454 PECOS PAC ID: 9638168602 Enrollment ID: O20040506001298 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Abacavir Sulfate Tablets, 60 mg. The NDA is based on the reference listed drug Ziagen® by ViiV Healthcare.
Support for eliminating existing exemptions, except for medical reasons, from immunization laws was among the policy recommendations adopted last weekend at the summer meeting of the Board of Regents of the American College of Physicians.
The New York Times reports that the nation's life-expectancy trend has reversed by four years since 1990 for the country's least-educated whites.
An improved physical condition with these exercises helps improve mobility in certain daily activities, increasing the quality of life of people with chronic kidney disease.
› Verified 6 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Abacavir Sulfate Tablets, 60 mg. The NDA is based on the reference listed drug Ziagen® by ViiV Healthcare.
Support for eliminating existing exemptions, except for medical reasons, from immunization laws was among the policy recommendations adopted last weekend at the summer meeting of the Board of Regents of the American College of Physicians.
The New York Times reports that the nation's life-expectancy trend has reversed by four years since 1990 for the country's least-educated whites.
An improved physical condition with these exercises helps improve mobility in certain daily activities, increasing the quality of life of people with chronic kidney disease.
› Verified 6 days ago
| Entity Name | Nani-ihp Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417376385 PECOS PAC ID: 3375767486 Enrollment ID: O20140611001371 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Abacavir Sulfate Tablets, 60 mg. The NDA is based on the reference listed drug Ziagen® by ViiV Healthcare.
Support for eliminating existing exemptions, except for medical reasons, from immunization laws was among the policy recommendations adopted last weekend at the summer meeting of the Board of Regents of the American College of Physicians.
The New York Times reports that the nation's life-expectancy trend has reversed by four years since 1990 for the country's least-educated whites.
An improved physical condition with these exercises helps improve mobility in certain daily activities, increasing the quality of life of people with chronic kidney disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Madhavi Ryali, MD 120 W 22nd St Ste 200, Oak Brook, IL 60523-1563 Ph: (630) 573-5000 | Madhavi Ryali, MD 133 E Brush Hill Rd Unit 301, Nephrology Associates Of Northern Illinois, Elmhurst, IL 60126-5661 Ph: (630) 832-2183 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Abacavir Sulfate Tablets, 60 mg. The NDA is based on the reference listed drug Ziagen® by ViiV Healthcare.
Support for eliminating existing exemptions, except for medical reasons, from immunization laws was among the policy recommendations adopted last weekend at the summer meeting of the Board of Regents of the American College of Physicians.
The New York Times reports that the nation's life-expectancy trend has reversed by four years since 1990 for the country's least-educated whites.
An improved physical condition with these exercises helps improve mobility in certain daily activities, increasing the quality of life of people with chronic kidney disease.
› Verified 6 days ago
William T O'rourke, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 172 E Schiller St, Elmhurst, IL 60126 Phone: 331-221-0000 Fax: 331-221-2312 | |
Maelen M Pantano, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 172 Schiller St, Elmhurst, IL 60126 Phone: 331-221-9001 Fax: 331-221-2315 | |
Ramier J Lehne, Nephrology Medicare: Medicare Enrolled Practice Location: 1200 S York St Ste 2000, Elmhurst, IL 60126 Phone: 331-221-9199 | |
Barbara E Potaczek, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 155 E Brush Hill Rd, Elmhurst, IL 60126 Phone: 331-221-8952 Fax: 331-221-3782 | |
Dr. Lalitha Dileep-ansal, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 155 E Brush Hill Rd, Elmhurst, IL 60126 Phone: 331-221-8952 Fax: 331-221-3782 | |
Dr. Omar Shamsi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1200 S York St, Suite 1240, Elmhurst, IL 60126 Phone: 331-221-6140 Fax: 331-221-3838 | |
Dhara Naik, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 172 E Schiller St, Elmhurst, IL 60126 Phone: 331-221-0000 Fax: 331-221-2312 |